A group led by the African Commission through the Africa Centres for Disease Control and Prevention (Africa CDC), yesterday launched the Africa Pathogen Genomics Initiative (Africa PGI), a $100 million, 4-year partnership to expand and integrate next-generation genomic sequencing (NGS) capabilities across the continent to improve health surveillance and lab networks and better tackle antimicrobial resistance (AMR).
Initial results from the FMT (fecal microbiota transplantation) National Registry indicate that FMT is highly effective for treating Clostridioides difficile infection (CDI), with a good safety profile, US researchers reported yesterday in Gastroenterology.
A white paper published today in Infection Control and Hospital Epidemiology calls on antibiotic stewardship programs (ASPs) to take steps to address the potential legal implications of stewardship activities.
Health advocacy group says states are more prepared to handle a public health threat this year than last year.
The main worry is the possible effect on weaker nations.
According to the latest weekly update from the Global Polio Eradication Initiative (GPEI) today, Pakistan tracked three new cases of wild poliovirus type 1 (WPV1) this past week, while several African and Pacific island nations reported a total of 22 vaccine-derived polio cases.
Yesterday the Centers for Disease Control and Prevention (CDC) said 35 more people have been sickened in an Escherichia coli outbreak tied to romaine lettuce grown near Salinas, California.
The outbreak total now stands at 102 illnesses in 23 states, with 4 states reporting their first cases.
According to a small study today in Pediatrics, maternal antibodies to measles passed to infants in pregnancy dropped quickly after birth, with 92% of infants showing antibodies below the protective threshold by 3 months. By 6 months of age, all the infants were unprotected against measles, based on their antibody levels.
Takeda's dengue vaccine candidate (TAK-003) is safe and effective against dengue virus, according to part 1 of phase 3 clinical trial results published yesterday in the New England Journal of Medicine.
Fully 56% of hospitals reported changing patient care or delaying therapy because of drug shortages.
